Delivery Order SPE2DB22D6029-SPE2DB25FLVDZ
- Not listed
- The Defense Logistics Agency awarded a $2,343.59 delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 MG/1.91 ML pen injectors on July 14, 2025, with an ultimate completion date of August 4, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under the company's broader...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of May 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,374.36 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 20, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a standard...
- The Defense Logistics Agency awarded a $7,030.77 delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 ml pen auto-injectors on September 3, 2025, with an ultimate completion date of September 24, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors, with a ceiling value of $4,687.18. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025. The award utilized competitive procedures with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the...
- The Defense Logistics Agency awarded a $18,748.72 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for TEZSPIRE 210 mg/1.91 mL pen injectors, with a completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency awarded a $4,687.18 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors valued at $4,687.18. This competitive award, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, which is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, valued at $2,343.59 with a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 through December 2026. The award carries no set-aside designation and was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp for TEZSPIRE 210 MG/1.91 ML pen injectors on May 2, 2025, with completion scheduled for May 23, 2025. This firm fixed-price, non-set-aside delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its corporate...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVDZDelivery Order
The Defense Logistics Agency awarded a $11,717.95 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for TEZSPIRE 210 mg/1.91 mL pen injectors, with completion targeted for June 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Performance will be executed from the contractor's corporate office located in Conshohocken, Pennsylvania. TEZSPIRE is a biologic medication used in the treatment of moderate-to-severe asthma, particularly for patients with a Type 2 inflammatory phenotype. This delivery order reflects the Defense Health Agency's pharmaceutical supply requirements through AmerisourceBergen's role as a prime pharmaceutical vendor under the DLA Medical Supply Chain. AmerisourceBergen serves as a critical distributor of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare systems and other federal health programs globally. The contract award demonstrates the contractor's continued competitiveness in fulfilling specialized pharmaceutical procurement needs for the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 5/30/25 |